查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2126476

氣喘管理穿戴裝置市場：策略性洞察與預測（2026-2031 年）

Wearables for Asthma Management Market - Strategic Insights and Forecasts (2026-2031)
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計氣喘管理穿戴裝置市場將維持 8.16% 的複合年成長率，從 2025 年的 991,559,000 美元成長到 2031 年的 1,587,315,000 美元。

受遠端患者監護模式轉移、藥物依從性日益重要以及數位健康工具融入慢性呼吸系統疾病護理等因素的推動，氣喘管理穿戴式裝置市場正經歷著重大變革。這一市場演變的特點在於，人們逐漸認知到穿戴式技術能夠解決氣喘管理中長期存在的挑戰，包括藥物依從性差、症狀監測、誘發因素識別和長期疾病管理。智慧吸入器、連網感測器、行動應用程式和分析平台的融合，使得獲取更客觀、更連續、更具實用性的呼吸健康數據成為可能。醫療專業人員擴大利用藥物依從性數據來識別高風險患者，並在病情惡化前進行干預，而患者則受益於即時回饋、提醒和個人化建議。隨著對連網吸入器技術、整合呼吸管理平台以及該市場實證醫學的大量投資，穿戴式裝置正逐漸成為氣喘藥物治療的重要補充。

市場促進因素

  • 氣喘治療中持續用藥依從性不足是推動穿戴式氣喘管理設備市場發展的主要因素。用藥依從性仍然是呼吸系統疾病管理中最普遍通報的挑戰之一。患者常會忽略維持治療、誤用吸入器，或在症狀改善後停止治療。配備感測器、提醒和使用追蹤功能的智慧吸入器能夠直接應對這些挑戰。醫療專業人員擴大利用用藥依從性數據來識別高風險患者，並在病情惡化前進行干預，從而推動了穿戴式氣喘管理設備的持續普及。遠端患者監護計畫的興起，透過增加對連網呼吸監測設備的需求，進一步加速了市場成長。隨著慢性病管理範圍從傳統臨床環境擴展到其他領域，醫療專業人員不斷投資於遠距醫療基礎設施。連網呼吸監測設備使臨床醫生能夠在兩次就診之間追蹤患者的症狀、吸入器使用情況、肺功能趨勢和環境暴露。這項功能與更廣泛的醫療保健目標相契合，即減少不必要的住院和急診醫療服務。隨著對基於價值的醫療保健服務的日益重視，穿戴式氣喘管理技術的商業價值也日益凸顯。保險公司和醫療保健系統越來越重視基於可衡量的患者療效而非僅基於服務量來評估治療方案。持續監測工具可以提供藥物依從性、症狀進展和治療效果的客觀證據。如果穿戴式氣喘技術能夠證明其可以減少急診治療的使用並改善疾病管理指標，那麼這將進一步增強其商業價值。感測器的微型化和行動連線技術的進步正在提升穿戴式呼吸設備的易用性。感測器性能的提升、電池效率的提升、無線連接能力的增強以及行動應用生態系統的完善，都在進一步提升穿戴式呼吸設備的易用性。

市場限制因素

  • 保險報銷體系的分散化是其廣泛應用的一大障礙。遠端監測設備、數位療法和連網呼吸平台的保險覆蓋範圍在不同國家和醫療體系之間差異顯著。整合到臨床工作流程的挑戰會進一步增加臨床醫師的行政負擔。醫療服務提供者正日益尋求將穿戴式裝置產生的數據直接整合到現有臨床系統中。在許多數位醫療領域，確保患者的持續參與仍然是一項挑戰。設備的初始部署並不一定能轉換為數年的持續使用。資料隱私和網路安全要求增加了開發成本和監管複雜性。臨床有效性檢驗要求對小規模的數位醫療公司而言可能是一項特別嚴峻的挑戰。

目錄

第1章執行摘要

第2章：市場概述

  • 市場概覽
  • 市場的定義
  • 調查範圍
  • 市場區隔

第3章：商業趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

第5章：氣喘管理穿戴裝置市場：依類型分類

  • 智慧吸入器
  • 穿戴式肺功能測量設備
  • 具備氣喘監測功能的活動追蹤器

第6章：氣喘管理穿戴裝置市場：依科技分類

  • 藍牙連接
  • 感測器技術
  • 行動應用與平台

第7章：氣喘管理穿戴裝置市場：依應用領域分類

  • 監測氣喘症狀
  • 追蹤用藥依從性
  • 尖峰流量監測
  • 找出觸發因素
  • 個體化氣喘管理

第8章：氣喘管理穿戴裝置市場：依最終用戶分類

  • 氣喘患者
  • 醫療服務提供方
  • 醫院和診所
  • 研究機構

第9章：氣喘管理穿戴裝置市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章：競爭環境與分析

  • 主要公司及策略分析
  • 市佔率分析
  • 合併、收購、協議和合作關係
  • 競爭環境儀錶板

第11章：公司簡介

  • Propeller Health（Now Part of ResMed）
  • Adherium Limited
  • Teva Pharmaceuticals
  • Cohero Health
  • Nuvoair
  • Astrazeneca Plc
  • Health Care Originals
  • Inspirx, Inc.
  • Amiko Digital Health Limited
  • Healthimation, LLC

第12章附錄

簡介目錄
Product Code: KSI061615993

The Wearables for Asthma Management Market, sustaining an 8.16% CAGR, is forecasted to rise from USD 991.559 million in 2025 to USD 1587.315 million in 2031.

The wearables for asthma management market is undergoing significant transformation driven by the paradigm shift toward remote patient monitoring, the growing emphasis on medication adherence, and the increasing integration of digital health tools into chronic respiratory care. The market's evolution is characterized by the recognition that wearable technologies can address persistent challenges in asthma management, including medication non-adherence, symptom monitoring, trigger identification, and long-term disease control. The convergence of smart inhalers, connected sensors, mobile applications, and analytics platforms is enabling more objective, continuous, and actionable respiratory health data. Healthcare providers are increasingly using adherence data to identify high-risk patients and intervene before disease control deteriorates, while patients benefit from real-time feedback, reminders, and personalized insights. The market is witnessing significant investment in connected inhaler technologies, integrated respiratory management platforms, and evidence generation, positioning wearables as a critical complement to pharmaceutical therapy in asthma management.

Market Drivers

  • Persistent medication non-adherence in asthma care represents the primary driver for the wearables for asthma management market. Medication adherence remains one of the most widely documented challenges in respiratory disease management. Patients frequently miss maintenance doses, use inhalers incorrectly, or discontinue therapy when symptoms improve. Smart inhalers equipped with sensors, reminders, and usage tracking capabilities directly address these challenges. Healthcare providers increasingly use adherence data to identify high-risk patients and intervene before disease control deteriorates, resulting in sustained growth in wearable asthma management utilization. The expansion of remote patient monitoring programs is further accelerating market growth through increased demand for connected respiratory monitoring. Healthcare providers continue to invest in remote care infrastructure as chronic disease management shifts beyond traditional clinical settings. Connected respiratory monitoring devices allow clinicians to track symptoms, inhaler use, lung function trends, and environmental exposures between appointments. This capability aligns with broader healthcare objectives focused on reducing avoidable hospital admissions and emergency care utilization. The growing emphasis on value-based healthcare delivery is strengthening the business case for wearable asthma technologies. Payers and healthcare systems are increasingly evaluating treatment approaches based on measurable patient outcomes rather than service volume alone. Continuous monitoring tools can provide objective evidence regarding medication use, symptom progression, and treatment effectiveness. This creates a stronger business case for wearable asthma technologies when they demonstrate reductions in acute care utilization or improvements in disease control metrics. Advances in sensor miniaturization and mobile connectivity are improving the usability of wearable respiratory devices. Improvements in sensor performance, battery efficiency, wireless connectivity, and mobile application ecosystems have improved the usability of wearable respiratory devices.

Market Restraints

  • Fragmented reimbursement frameworks create barriers to broader adoption. Coverage policies for remote monitoring devices, digital therapeutics, and connected respiratory platforms vary significantly across countries and healthcare systems. Clinical workflow integration challenges can create an additional administrative burden for clinicians. Healthcare providers increasingly require wearable-generated data to integrate directly into existing clinical systems. Patient engagement sustainability remains difficult across many digital health categories. Initial device adoption does not always translate into sustained use over multiple years. Data privacy and cybersecurity requirements increase development costs and regulatory complexity. Clinical validation requirements can be particularly challenging for smaller digital health companies.

Technology and Product Insights

  • The technology landscape is characterized by the growing importance of smart inhalers, connected sensors, and integrated respiratory management platforms. Smart inhalers represent the most commercially important segment because they directly address one of asthma management's most persistent challenges: medication adherence. Unlike broader wellness-oriented wearables, smart inhalers are closely linked to therapeutic intervention and generate data directly associated with treatment compliance. Healthcare providers increasingly value smart inhalers because they produce objective usage records rather than relying on patient self-reporting. These devices can record inhaler actuation events, provide dose reminders, identify usage patterns, and transmit data to clinicians or caregivers. Such capabilities support earlier intervention when adherence declines or rescue inhaler use increases. The segment analysis reveals that competition increasingly centers on ecosystem development rather than sensor technology alone. Companies that combine inhaler connectivity with symptom tracking, environmental monitoring, predictive analytics, and telehealth integration are likely to strengthen their competitive position relative to suppliers offering standalone monitoring functionality. North America represents the largest commercial opportunity due to extensive digital health investment, high healthcare expenditure, established remote monitoring infrastructure, and widespread smartphone adoption. European respiratory disease management remains a priority across several healthcare systems, with countries including Germany, the United Kingdom, and France continuing to expand digital healthcare capabilities. Asia Pacific countries with large patient populations, increasing healthcare digitization, and expanding smartphone penetration are expected to account for substantial regional demand. The integration of analytics platforms is becoming increasingly important as providers and healthcare systems evaluate integration with electronic health records, compatibility with existing inhaler platforms, patient usability, battery life, and data analytics capabilities.

Competitive and Strategic Outlook

  • The competitive landscape exhibits characteristics of a technology-driven and healthcare-integration-focused environment where device functionality remains important, but competitive differentiation increasingly depends on software capabilities, analytics, interoperability, clinical evidence, and healthcare ecosystem integration. Propeller Health, now operating within ResMed's broader digital health portfolio, has established a strong position through connected inhaler technologies and respiratory monitoring platforms, with integration within a larger respiratory care ecosystem providing advantages in data analytics, patient engagement, and healthcare provider connectivity. Adherium Limited continues to focus on medication adherence monitoring solutions. Teva Pharmaceuticals has pursued connected inhaler initiatives linked to pharmaceutical therapy management. AstraZeneca's involvement reflects growing pharmaceutical interest in combining therapeutics with digital disease management tools. NuvoAir, Cohero Health, Amiko Digital Health, Health Care Originals, Inspirx, and Healthimation are pursuing various combinations of remote monitoring, digital therapeutics, respiratory analytics, and patient engagement technologies. Competition increasingly centers on demonstrating clinical outcomes, securing healthcare partnerships, and integrating respiratory monitoring into broader chronic disease management workflows. Barriers to entry are increasing as healthcare providers demand stronger clinical validation, cybersecurity compliance, regulatory approval capabilities, and interoperability standards. Recent key developments include Masimo securing FDA clearance for Radius VSM, a body-worn continuous monitoring device that enables remote tracking of physiological parameters with respiratory monitoring applications. Cipla introduced Ciposcillo, an advanced oscillometer for early assessment of asthma and other obstructive airway diseases. Signant Health acquired Ametris, adding wearable-derived digital outcome measurement capabilities applicable to asthma studies and decentralized clinical trials. Aptar Digital Health obtained FDA clearance for HeroTracker Sense, a Bluetooth-enabled inhaler attachment that converts conventional inhalers into connected devices.

Short Conclusion

  • The wearables for asthma management market is positioned for sustained growth driven by the convergence of medication adherence challenges, remote monitoring expansion, and technological innovation. The transition from standalone devices toward integrated respiratory management platforms represents a fundamental shift in chronic disease management. While challenges related to reimbursement fragmentation, workflow integration, and patient engagement persist, strategic investments in ecosystem development, clinical evidence, and healthcare partnerships are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with wearables evolving into a critical complement to pharmaceutical therapy, supporting adherence, symptom monitoring, and improved outcomes across global healthcare systems.

Key Benefits of this Report

  • Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

  • Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation, and trade analysis
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Smart Inhalers
  • 5.3. Wearable Spirometers
  • 5.4. Activity Trackers with Asthma Monitoring

6. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Bluetooth Connectivity
  • 6.3. Sensor Technology
  • 6.4. Mobile Apps and Platforms

7. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Asthma Symptom Monitoring
  • 7.3. Medication Adherence Tracking
  • 7.4. Peak Flow Rate Monitoring
  • 7.5. Trigger Identification
  • 7.6. Personalized Asthma Management

8. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Patients With Asthma
  • 8.3. Healthcare Providers
  • 8.4. Hospitals And Clinics
  • 8.5. Research Institutions

9. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Propeller Health (Now Part of ResMed)
  • 11.2. Adherium Limited
  • 11.3. Teva Pharmaceuticals
  • 11.4. Cohero Health
  • 11.5. Nuvoair
  • 11.6. Astrazeneca Plc
  • 11.7. Health Care Originals
  • 11.8. Inspirx, Inc.
  • 11.9. Amiko Digital Health Limited
  • 11.10. Healthimation, LLC

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations